Cargando…
Imatinib is not a potent anti-SARS-CoV-2 drug
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527150/ https://www.ncbi.nlm.nih.gov/pubmed/32999432 http://dx.doi.org/10.1038/s41375-020-01045-9 |
| _version_ | 1783588996174053376 |
|---|---|
| author | Zhao, Helong Mendenhall, Michelle Deininger, Michael W. |
| author_facet | Zhao, Helong Mendenhall, Michelle Deininger, Michael W. |
| author_sort | Zhao, Helong |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7527150 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75271502020-10-01 Imatinib is not a potent anti-SARS-CoV-2 drug Zhao, Helong Mendenhall, Michelle Deininger, Michael W. Leukemia Correspondence Nature Publishing Group UK 2020-09-30 2020 /pmc/articles/PMC7527150/ /pubmed/32999432 http://dx.doi.org/10.1038/s41375-020-01045-9 Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correspondence Zhao, Helong Mendenhall, Michelle Deininger, Michael W. Imatinib is not a potent anti-SARS-CoV-2 drug |
| title | Imatinib is not a potent anti-SARS-CoV-2 drug |
| title_full | Imatinib is not a potent anti-SARS-CoV-2 drug |
| title_fullStr | Imatinib is not a potent anti-SARS-CoV-2 drug |
| title_full_unstemmed | Imatinib is not a potent anti-SARS-CoV-2 drug |
| title_short | Imatinib is not a potent anti-SARS-CoV-2 drug |
| title_sort | imatinib is not a potent anti-sars-cov-2 drug |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527150/ https://www.ncbi.nlm.nih.gov/pubmed/32999432 http://dx.doi.org/10.1038/s41375-020-01045-9 |
| work_keys_str_mv | AT zhaohelong imatinibisnotapotentantisarscov2drug AT mendenhallmichelle imatinibisnotapotentantisarscov2drug AT deiningermichaelw imatinibisnotapotentantisarscov2drug |